<div class="fbot-conversation">
  <div class="fbot-bubble fbot-bubble-bot">
    <span class="fbot-bubble-src"
      ><img
        src="https://srrdemobucket.s3.amazonaws.com/botwithbg.png"
        alt="Bot"
        class="user-img" /></span
    ><span class="fbot-bubble-text">Hi, how can i help you today?</span>
  </div>
  <div class="fbot-bubble fbot-bubble-usr">
    <span class="fbot-bubble-src"
      ><img
        src="https://master-boomi-flow-assets-prod-us-east-1.s3.amazonaws.com/2d2043cd-3e4e-40f4-a7bb-397c662521f2/humanface.png"
        alt="User"
        class="user-img" /></span
    ><span class="fbot-bubble-text"
      >what are all the studies are in phase 1. </span
    ><br />
  </div>
  <div>
    <img
        src="https://srrdemobucket.s3.amazonaws.com/botwithbg.png"
        alt="Bot"
        class="user-img" />
  
  <div class="fbot-bubble fbot-bubble-bot">
    <span class="fbot-bubble-src"
      ></span
    ><span class="fbot-bubble-text"
      >The studies that are in Phase 1 are: ALN-TTRSC04-001 (TTRSC04 FIH),
      ALN-BCAT-001 (BCAT FIH), ALN-AGT01-006 (zilebe JPN), ALN-HTT02-001 (HTT02
      Ph I FIH), and ALN-APP-001 (APP EoAD FIH).</span
    >

  </div>
</div>
</div>
